Search results
GSK ups 2024 guidance as HIV drugs and new vaccines boost its bottom line
Market Watch· 5 days agoThe British firm beat analysts’ forecasts in posting a 17% increase in its core operating profits,...
Amgen (AMGN) Q1 Earnings Top, Stock Up on Obesity Drug Update
Zacks via Yahoo Finance· 3 days agoAmgen (AMGN) beats first-quarter 2024 estimates for earnings and sales. Amgen is "very encouraged"...
Azerbaijan Based Banking Services Providers Have Reportedly Forged Financial Links With US...
Crowdfund Insider· 3 days agoOrganized by the U.S.-Azerbaijan Chamber of Commerce (USACC), a Washington, D.C.-based trade association, in partnership with Azerbaijan Banks Association, this mission aimed to foster ties ...
GSK ups 2024 guidance as HIV drugs and new vaccines boost its bottom line
Morningstar· 5 days agoGSK on Tuesday upped its 2024 profit guidance, as surging sales of its HIV drugs and recently launched shingles vaccine saw it beat analyst expectations in the first quarter of the year. The ...
Earnings call: Boston Properties (BXP) Q1 2024 results show resilience By Investing.com
Investing.com· 4 days agoBoston Properties, Inc. (NYSE:BXP) has reported its first quarter 2024 earnings, highlighting a...
J&J, Bristol Myers lose challenges to US drug price negotiation program By Reuters
Investing.com· 7 days agoU.S. District Judge Zahid Quraishi in Trenton, New Jersey, became the fourth federal judge to uphold...
Angle PLC Announces New Commercial Agreement with Large Pharma
Digital Journal· 3 days agoANGLE commissioned to develop a Parsortix-based Androgen Receptor detection assay for use in prostate cancer studies GUILDFORD, SURREY / ACCESSWIRE / May 3, 2024 / ANGLE plc (AIM:AGL)(OTCQX: ...
J&J, Bristol Myers lose challenges to US drug price negotiation program
Reuters· 7 days ago, opens new tab to a law requiring them to negotiate the prices of their blockbuster blood clot...
Cullinan Therapeutics appoints new CFO By Investing.com
Investing.com· 6 days agoCullinan Therapeutics, Inc. (NASDAQ: CGEM), a biopharmaceutical company known for its work on...
Earnings call: Boston Properties (BXP) Q1 2024 results show resilience
Investing.com· 4 days agoBoston Properties, Inc. (NYSE: BXP ) has reported its first quarter 2024 earnings, highlighting a...